New insights in ghrelin orexigenic effect
Loading...
Official URL
Full text at PDC
Publication date
2010
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Karger
Citation
Carlos Diéguez, Kátia Da Boit, Marta G. Novelle, Pablo B. Martínez de Morentin, Rubén Nogueiras, Miguel López, 2010. "New Insights in Ghrelin Orexigenic Effect", Pituitary Today II: New Molecular, Physiological and Clinical Aspects, E. Arzt, M. Bronstein, M. Guitelman
Abstract
Ghrelin, a peptide hormone first discovered as the endogenous ligand of the growth hormone secretagogue receptor (GHS-R), is predominantly produced and released into the circulation by ghrelin cells (X/A-like) of the stomach fundus cells. Ghrelin has multiple actions in multiple tissues. In particular, it is the most potent known endogenous orexigenic peptide, and plays a significant role in glucose homeostasis: deletion of the genes encoding ghrelin and/or its receptor prevents high-fat diet from inducing obesity, increases insulin levels, enhances glucose-stimulated insulin secretion and improves peripheral insulin sensitivity. In addition to its already mentioned roles, ghrelin has other activities including stimulation of pituitary hormones secretion, regulation of gastric and pancreatic activity, modulation of fatty acid metabolism via specific control of AMP-activated protein kinase (AMPK), and cardiovascular and hemodynamic activities. In addition, modulation of cartilage and bone homeostasis, sleep and behavioral influences, and modulation of the immune system, as well as effects on cell proliferation, are other relevant actions of ghrelin. In this review, we summarize several aspects of ghrelin effects at hypothalamic level and their implications in the control of food intake and energy balance.
Description
This work was supported by the European Community (Health-F2–2008–223713, ‘REPROBESITY’), and by Xunta de Galicia (ML: GRC2006/66), Fondo Investigationes Sanitarias (ML: PI061700), Ministerio de Educacion y Ciencia (ML: RyC-2007–00211 and RN: RYC-2008–02219), BFU 2008 (C.D. and M.L.). CIBER de Fisiopatología de la Obesidad y Nutrición is an initiative of ISCIII, Spain.